LSV Asset Management Holds Holdings in Humana Inc. (HUM)
LSV Asset Management held its position in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,900 shares of the insurance provider’s stock at the close of the second quarter. LSV Asset Management’s holdings in Humana were worth $2,863,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in HUM. Guardian Life Insurance Co. of America boosted its holdings in Humana by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 4 shares during the period. Independent Portfolio Consultants Inc. boosted its holdings in Humana by 22.1% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after purchasing an additional 94 shares during the period. Point72 Asia Hong Kong Ltd bought a new position in Humana in the 1st quarter valued at $128,000. Fiduciary Trust Co. bought a new position in Humana in the 2nd quarter valued at $135,000. Finally, Westbourne Investment Advisors Inc. bought a new position in Humana in the 2nd quarter valued at $205,000. 95.12% of the stock is owned by institutional investors.
HUM has been the subject of several analyst reports. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, May 23rd. Leerink Swann raised their price target on shares of Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a report on Tuesday, May 30th. Royal Bank Of Canada reissued a “hold” rating and issued a $214.00 price target on shares of Humana in a report on Monday, June 5th. Morgan Stanley initiated coverage on shares of Humana in a report on Tuesday, June 6th. They issued an “overweight” rating and a $262.00 price target for the company. Finally, Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a report on Friday, June 9th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $244.35.
TRADEMARK VIOLATION WARNING: “LSV Asset Management Holds Holdings in Humana Inc. (HUM)” was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/09/20/lsv-asset-management-holds-holdings-in-humana-inc-hum.html.
In other news, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at $3,421,920. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP M Todoroff Christopher sold 22,935 shares of the stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares in the company, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. Insiders have sold 60,566 shares of company stock valued at $15,326,746 in the last quarter. 0.80% of the stock is owned by company insiders.
Humana Inc. (NYSE HUM) opened at 240.04 on Wednesday. The stock has a market cap of $34.69 billion, a PE ratio of 19.75 and a beta of 0.87. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $259.76. The company has a 50-day moving average of $250.95 and a 200-day moving average of $232.23.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The business had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the business earned $2.30 earnings per share. On average, equities analysts forecast that Humana Inc. will post $11.55 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Tuesday, August 29th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.60 annualized dividend and a yield of 0.67%. Humana’s dividend payout ratio (DPR) is currently 13.06%.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.